Content about Nootropics

August 1, 2011
Federal court upholds Lilly patent

A federal court has upheld Eli Lilly's patent covering a drug used to treat attention deficit hyperactivity disorder, Lilly said Friday.

May 9, 2011
Impax confirms patent challenge for generic Concerta

Alza Corp. is attempting to block Impax Labs from developing a generic version of Alza's attention deficit hyperactivity disorder treatment.

May 2, 2011
Watson's generic Concerta enters market

Watson Pharmaceuticals has launched an authorized generic version of a Johnson & Johnson drug for treating attention deficit hyperactivity disorder through a subsidiary, Watson said Monday.

April 11, 2011
Pfizer, Medivation 'disappointed' in phase-3 trial results for Dimebon

A drug originally developed by scientists in the Soviet Union to treat allergies and currently under investigation by Pfizer and Medivation did not yield significant results in a late-stage clinical trial of patients with Huntington disease, a disorder that leads to cognitive decline, the companies said Monday.

April 6, 2011
Shire files lawsuit against Watson over Adderall XR

British drug maker Shire has filed suit against Watson Pharmaceuticals and subsidiaries, alleging patent infringement in a case concerning a drug used to treat attention deficit hyperactivity disorder.

March 30, 2011
Valeant seeks to buy Cephalon

Canadian drug maker Valeant Pharmaceuticals has proposed to buy Cephalon for $5.7 billion, Valeant said Tuesday.

February 25, 2011
Watson seeks regulatory approval for generic Adderall XR

Watson Labs is hoping to be the first to market a generic version of a popular drug for attention deficit hyperactivity disorder.

February 4, 2011
Sun's generic Razadyne ER granted regulatory approval

The Food and Drug Administration has approved a generic Alzheimer’s disease treatment from Sun Pharmaceutical Industries.

January 21, 2011
Watson forecasts successful year

Generic drug maker Watson Pharmaceuticals expects sales of $4.2 billion for 2011, the company said Friday.

November 30, 2010
Impax confirms patent challenge for generic Concerta

A generic version of a drug indicated to treat attention deficit hyperactivity disorder has hit a roadblock.

November 1, 2010
Watson to market, distribute authorized generic ADHD drug

Generic drug maker Watson Pharmaceuticals will distribute an authorized generic version of a drug used...

October 24, 2010
FDA approves REMS for Nuvigil, Provigil

The Food and Drug Administration has approved risk evaluation and mitigation strategies for two sleep...

September 27, 2010
Endo boosts portfolio with Qualitest acquisition

Endo Pharmaceuticals will acquire generic drug maker Qualitest Pharmaceuticals for $1.2 billion, Endo said Tuesday....

September 1, 2010
Actavis' generic Strattera gets OK from FDA

The Food and Drug Administration has approved a generic drug made by Actavis for treating...

August 31, 2010
FDA approves Sun's generic Strattera

A generic drug maker has received regulatory approval for its version of an attention deficit...

August 12, 2010
District court rules against Lilly in Strattera patent suit

The U.S. District Court for the District of New Jersey has ruled against drug maker...

July 6, 2010
FDA approves expanded use of Daytrana

The Food and Drug Administration has approved a drug made by Shire for treating attention...

March 29, 2010
FTC wins pay-for-delay battle

The Federal Trade Commission’s crusade against patent settlements between branded and generic drug makers moved...

March 29, 2010
Jet lag treatment receives complete response letter

The Food and Drug Administration declined to approve a Cephalon drug as a treatment for...

March 2, 2010
Pfizer, Medivation's trial of investigational Alzheimer's treatment falls short

Hopes that a drug Soviet scientists created in the 1980s might provide a treatment for...

February 1, 2010
Taro gets go-ahead for epilepsy drug

The Food and Drug Administration has approved a generic epilepsy drug made by Taro Pharmaceutical...

January 10, 2010
Mylan confirms first-to-file patent challenge for Nuvigil generic

Drug maker Cephalon and its French subsidiary sued generic drug maker Mylan in connection with...

January 5, 2010
Watson seeks FDA approval for sleep disorder treatment

Watson has filed an abbreviated new drug application for the generic version of a sleep...

© 2013 Drug Store News. All Rights Reserved.